Medpace Holdings (MEDP) Cash & Equivalents Growth (3y) (2018 - 2026)
Medpace Holdings (MEDP) Cash & Equivalents Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -2.23% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -8.24% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 21.66% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 15.43% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 9.23% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 39.74% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -10.00% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -12.05% |
| 10 | Medpace Holdings | 13.30 Bn | 12.64 Bn | 196.33 Mn | 140.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 140.50% |
| Dec 31, 2025 | 160.05% |
| Sep 30, 2025 | 109.56% |
| Jun 30, 2025 | 2.88% |
| Mar 31, 2025 | 74.66% |
| Dec 31, 2024 | 13.22% |
| Sep 30, 2024 | 18.14% |
| Jun 30, 2024 | 14.65% |
| Mar 31, 2024 | 6.93% |
| Dec 31, 2023 | -4.04% |
| Sep 30, 2023 | -24.27% |
| Jun 30, 2023 | -37.58% |
| Mar 31, 2023 | -29.52% |
| Dec 31, 2022 | -40.16% |
| Sep 30, 2022 | -26.87% |
| Jun 30, 2022 | 28.41% |
| Dec 31, 2021 | 3,939.21% |
| Sep 30, 2021 | 161.64% |
| Jun 30, 2021 | 147.98% |
| Mar 31, 2021 | 146.42% |